Loxapine: all 21 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for AgitationTerminatedNCT03110900Phase 4Results posted
- ADASUVE-Lorazepam Drug-Drug InteractionCompletedNCT01877642Phase 4Results posted
- ADASUVE 2-dose Thorough QT/QTc StudyCompletedNCT01854710Phase 4Results posted
- Staccato Loxapine Thorough QT/QTc StudyCompletedNCT00874237Phase 1Results posted
- Staccato Loxapine in Migraine (Out Patient)CompletedNCT00825500Phase 2Results posted
- Staccato Loxapine Pulmonary Safety in Healthy VolunteersCompletedNCT00789360Phase 1Results posted
- Staccato Loxapine in Agitated Patients With Bipolar DisorderCompletedNCT00721955Phase 3Results posted
- Staccato Loxapine in Agitated Patients With SchizophreniaCompletedNCT00628589Phase 3Results posted
- Staccato Loxapine in Migraine (in Clinic)CompletedNCT00489476Phase 2Results posted
- Staccato Loxapine Single Dose PKCompletedNCT00444028Phase 1Results posted
- Staccato Loxapine in Agitation (Proof of Concept)CompletedNCT00369577Phase 2Results posted
- A Study of Staccato Loxapine (ADASUVE®) for InhalationStatus unknownNCT04148963Phase 3
- Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic PainTerminatedNCT02820519Phase 2
- Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic MedicationCompletedNCT02184767Phase 1
- Loxapine in the Management of Restlessness During Mechanical Ventilation WeaningCompletedNCT01193816Phase 4
- Staccato Loxapine Pulmonary Safety in Patients With AsthmaCompletedNCT00890175Phase 1
- Staccato Loxapine Pulmonary Safety in Patients With COPDCompletedNCT00889837Phase 1
- Staccato Loxapine PK in Smokers and NonsmokersCompletedNCT00873769Phase 1
- Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mgCompletedNCT00648778Phase 1
- Randomized Double-blind Trial of Midazolam and Loxapine in Agitated PatientsTerminatedNCT00290082Phase 3
- Loxapine and Weaning From VentilatorCompletedNCT00122733Not applicable